Ayse's Transformation: Melagenina Plus® for Vitiligo Repigmentation
All Patient Stories
🇹🇷Vitiligo

Ayse's Transformation: Melagenina Plus® for Vitiligo Repigmentation

After years of living with vitiligo, Ayse traveled to Cuba for Melagenina Plus® therapy. The placental extract treatment combined with UV therapy produced visible repigmentation.

28 days treatment Ayse K. from Turkey

"For the first time in years, I can see my natural skin color returning. The treatment was painless and the team was incredibly supportive."

— Ayse K., Turkey

Living with Vitiligo

Ayse, a 34-year-old from Istanbul, had been living with non-segmental vitiligo for over 10 years. The white patches on her face, hands, and neck affected her confidence significantly. She had tried various topical treatments without success.

Discovering Melagenina Plus®

Ayse learned about Melagenina Plus® — the Cuban placental extract therapy for vitiligo — through online research. She was encouraged by the non-invasive nature of the treatment and contacted La Pradera for a consultation.

The Treatment Protocol

Ayse's 28-day program included daily application of Melagenina Plus® to affected areas, combined with controlled UV light therapy sessions. The dermatology team monitored her progress with regular photographic documentation.

Visible Results

By the end of the second week, Ayse noticed repigmentation beginning on her face — the area that typically responds best. The patches on her neck also showed improvement. Her dermatologist at La Pradera provided realistic expectations about the hands, which can be more resistant.

Post-Treatment Care

Ayse returned to Istanbul with detailed post-treatment care instructions and a supply of Melagenina Plus® for continued application. Her dermatologist in Turkey continues to monitor her progress, and the repigmentation has continued to improve since her return.

Ready to Start Your Journey?

Request a consultation with our medical team to discuss your treatment options.

We use cookies to improve your experience and analyze traffic. By continuing, you agree to our use of cookies. Privacy Policy